Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Forward Pharma Appeals The Initial Decision In The U.S. Patent Interference To The Federal Circuit May 30, 2017 Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017 Omeros To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 March 9, 2017
Forward Pharma Appeals The Initial Decision In The U.S. Patent Interference To The Federal Circuit May 30, 2017
Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017
Omeros To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 March 9, 2017
